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ABSTRACT 
FAM20 (family with sequence similarity 20) members in humans consist of 
FAM20A, FAM20B and FAM20C. The mutations of FAM20A in humans lead to 
Amelogenesis Imperfecta (AI), gingival hyperplasia and enamel renal syndrome 
(ERS) in humans. Mutations of FAM20B in Danio rerio result in decreased cartilage 
matrix production and skeletal defects. Mutations in FAM20C leads to neonatal 
lethal osteosclerotic bone dysplasia in humans, known as Raine syndrome. One of 
the mutants is FAM20C-D478A. FAM20C intracellularly functions as a Golgi casein 
kinase. It phosphorylates secretory pathway proteins within S-x-E motif (where S is 
Ser, X is any amino acid, and E is Glu). Extracellular role of FAM20C has also been 
suggested as a growth and differentiation factor, and the exogenous FAM20C 
treatment accelerates MC3T3-E1 osteoblast differentiation and mineralization in 
vitro. The first purpose of this study was to purify FAM20C protein. HEK 293 cells 
were transfected with FAM20C expression vectors, cell clones that overexpress 
FAM20C were isolated and FAM20C protein was collected and purified. The 
Western blot results of purified FAM20C showed higher bands, around 100 kDa and 
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170 kDa, than expected molecular weight, 66 kDa. Post-translational modification 
was thought to be the possible reason. Therefore, the second purpose was to find 
binding proteins of FAM20C by mass spectrometry protein identification analysis to 
check if FAM20C has other post-modifications, such as glycosylation. FAM20C-WT 
and FAM20C-D478A proteins were chosen to perform the study since FAM20C-
D478A was investigated in previous studies of Golgi casein kinase, FAM20C, and 
was found to have no kinase activity.   
In this study, periostin was identified to bind to FAM20C and the binding of 
these 2 proteins was confirmed by immunoprecipitation and Western blot analysis. 
Since FAM20C functions as a secretory kinase, it is suggested that periostin may 
be a substrate for FAM20C kinase. Further investigation is needed to determine the 
presence of phosphorylation in periostin and its role in periosteum and periodontal 
ligament. 
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1. Introduction     
 
Periodontium  
 
Periodontium consists of gingiva, alveolar mucosa, alveolar bone, cementum 
and periodontal ligament. It is a supporting apparatus for the teeth in function and 
occlusion [1. Antonio Nanci, Dieter D. Bosshardt, 2006, 2. Anthony Palumbo].   
The gingiva is firmly bound to the underlying bone and is continuous with the 
alveolar mucosa which is located apically and movable. Type I collagen is the 
predominant component in the connective tissue of gingiva. There are also cells, 
nerves, blood vessels and ground substance in the connective tissue. The cells are 
mainly fibroblasts, mast cells and immunologic cells. The ground substance is 
composed of glycosaminoglycans and proteoglycans. It helps water retention which 
can support the functional force and maintain the shape and structure of the gingival 
tissue [2. Anthony Palumbo]. 
Alveolar bone is the osseous tissue in the maxilla and mandible which 
houses and supports the sockets of the teeth. Bones are constantly remodeled 
since they have to respond to the forces of mastication. It is created by osteoblasts 
and continues remodeling throughout life. Osteoblasts produce type I collagen, the 
major bone matrix protein which is then mineralized with calcium and phosphate, 
forming hydroxyapatite [2. Anthony Palumbo]. Type I collagen is the predominant 
organic component, up to 90%. Many noncollagenous proteins are found in bone, 
such as bone sialoprotein, dentin matrix protein1, osteopontin, osteocalcin and 
proteoglycans, etc [1. Antonio Nanci, Dieter D. Bosshardt, 2006].  
 
Cementum is the hard, avascular connective tissue that coats the root of 
teeth. It is classified into acellular and cellular types and serves primarily to attach 
the principal periodontal ligament fibers. It is made of collagen fibers within a 
mineralized matrix [1. Antonio Nanci, Dieter D. Bosshardt, 2006].The composition of 
cementum is similar to bone. Cementum is composed of 50% mineral and 50% 
organic matrix [2.Anthony Palumbo]. 
Periodontal ligament is the soft, unmineralized connective tissue between the 
cementum and the alveolar bone. It is a connective tissue well adapted to its main 
function, supporting teeth in their sockets and as a shock absorber against 
mastication impact. It is also a sensory receptor and a cell reservoir for tissue 
homeostasis, repair and regeneration [1. Antonio Nanci, Dieter D. Bosshardt, 2006]. 
Periodontal ligament cells are a heterogeneous population of cells that can 
differentiate into fibroblasts, cementoblasts, and osteoblasts [3. Nohutcu RM, 
McCauley LK,1997, 4. McCulloch CA, Bordin S,1991].Several noncollagenous 
proteins are found in periodontal ligament, including alkaline phosphatase, 
proteoglycans, and glycoproteins. Interestingly, despite the mechanical stress of 
mastication or orthodontic forces under physiological conditions, the periodontal 
ligament always maintains its width unmineralized. The issue of how periodontal 
ligament maintains uncalcified between two calcified tissues remains unsolved and 
	 2	
will be discussed in this thesis [1. Antonio Nanci, Dieter D. Bosshardt, 2006, 2. 
Anthony Palumbo, 5. Na Wei, Haiyang Yu, 2011].   
 
Components involving in mineralization 
 
Considering the mechanism of bone mineralization, three main components 
are involved: inorganic substance, collagen fibrils, and non-collagenous proteins, 
constituting bone organic matrix. The forth component is cells that can produce 
organic matrix, control the flux of ions into the extracellular matrix and release 
signals to begin or end the mineralization process [6. Ermanno Bonucci, 2013. ]. 
 
Mineral (HA, Hydroxyapatite) 
 
The term apatite indicates a mineral structure. Biologically mineralized 
crystals are typically formed in an organic matrix with precise regulation of synthetic 
mechanisms through proteins. Biogenic apatite varies in several ways from the 
geologically produced mineral. First, biogenic apatite has a smaller crystal size, 
which has a higher surface area, thus permitting additional adsorption of ions and 
molecules on the apatite surface. Second, the biogenic apatite contains significant 
carbonate substitutions. F- ions, for example, are readily incorporated into the HA 
lattice, forming a less soluble phase of calcium phosphate. Finally, biological 
mineral tends to attain high crystallinity and a more organized structure on the time 
scale of days or months rather than years [7. Liam C. Palmer, Christina J. 
Newcomb, 2008].   
HA is the calcium phosphate mineral found in vertebrate bones and teeth. In 
the early 1900s, X-ray diffraction patterns identified ground bone to be similar to 
geological HA, Ca5(PO4)3(OH). Later studies have shown that the ratios of Ca/P in 
bone can vary significantly because the body utilizes bone as a reservoir to 
maintain homeostatsis with respect to calcium, magnesium, and phosphate ions. 
Carbonated HA, Ca10(PO4,CO3) 6(OH)2, is the most abundantly  produced 
phosphate mineral in bones and teeth. The ratios of Ca/P in enamel and dentin 
more closely resemble the stoichiometric ratio, since teeth are not typically involved 
in maintaining ion homeostasis [7. Liam C. Palmer, Christina J. Newcomb, 2008]. 
The inorganic substance of bone is a calcium phosphate, regarded as 
hydroxyapatite with the formula Ca10(PO4)6(OH)2. The size and composition of bone 
apatite changes with age, so does Ca/P ratio [ 6. Ermanno Bonucci, 2013, 8. Adele 
L. Boskey,2007]. 
 
Collagen fibrils 
Collagens comprise a large family of triple helical proteins and are the most 
abundant proteins in vertebrates. There are now at least 29 genetically distinct 
types of collagen. Type I collagen is the most abundant structural protein in 
vertebrates. It is composed of two α1 chains and one α2 chain, forming a long 
uninterrupted triple helical structure with short non-triple helical telopeptides at both 
the N- and C- termini. One of the critical factors for the structural and biomechanical 
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functions of type I collagen fibrils are the PTMs (post-translational modifications) of 
peptidyl lysine residues [9. Mitsuo Yamauchi, Marnisa Sricholpech, 2012 ]. 
 In the cell, specific peptidyl lysine residues both in the helical and nonhelical 
domains can be hydroxylated forming 5-hydroxylysine, which then can be 
glycosylated. The type and extent of collagen glycosylation varies among different 
collagen types and varies depending on the functional regions within the tissue, 
maturation and pathological conditions. In bone, for instance, alterations in the 
levels of collagen glycosylation have been reported in several bone /skeletal 
disorders, such as osteogenesis imperfecta [81. Tenni R, Valli M ,1993. 82. Brenner 
RE, Vetter U,1990. 83. Cetta G, De Luca G,1983.] and postmenopausal 
osteoporosis [84. Michalsky M, Norris-Suarez K, 1993. 85. Moro L, Bettica P,1997. 
86. Moro L, Suarez KN, 1997], suggesting a role of collagen glycosylation in bone 
mineralization [9. Mitsuo Yamauchi, Marnisa Sricholpech, 2012 ]. 
 Outside the cell, an enzymatic oxidative deamination occurs on some 
telopeptidyl lysine and hydroxylysine residues producing the reactive aldehydic 
residues. The aldehydes can initiate a series of condensation reactions to form 
extensive covalent intra- and intermolecular cross-links. The initial intra- and 
intermolecular crosslinks can then further mature into multivalent crosslinks, which 
demonstrate the highly specific molecular packing arrangement in the fibril and 
show tissue specificity. The cross-links are the final step of collagen biosynthesis 
and are critical in providing the fibril with stability and the biomechanical functions [9. 
Mitsuo Yamauchi, Marnisa Sricholpech, 2012 ]. 
Collagen is composed largely of the amino acids glycine, proline, and 
hydroxyproline, often as Gly-X-Y repeats (where X and Y are either proline or 
hydroxyproline). Tropocollagen, the subunit of collagen fibrils formed of three 
polypeptide strands, assemble in a parallel, quarter-staggered arrangement. There 
is a 40 nm gap, also called the “hole zone” with 27 nm of overlap between adjacent 
units. This spacing give rise to the basic 67 nm repeat unit and banding observed 
by electron microscopy, also known as the D-period. The hole zones are critical in 
mineralization, as they appear to be the site of mineral nucleation. The crystals 
appear to grow and proliferate from this area. The size of this gap also appears to 
constrain the mineral growth [7. Liam C. Palmer, Christina J. Newcomb, 2008]. 
Type I collagen is the most abundant component of the bone matrix and may 
be able to induce the process of calcification, especially in combination with 
phosphoproteins. That is, the collagen-phosphoproteins complex facilitate 
calcification better than collagen alone [10. Glimcher MJ,1989]. Collagen provides 
the template for mineral deposition in bone and dentin. 
 
Non-collagenous components 
Non-collagenous components include proteoglycans, phosphoproteins, and 
phospholipids.  In addition to type I collagen, the ECM of bone and dentin contains 
several noncollagenous proteins (NCPs). These NCPs are believed to actively 
promote and control mineralization of collagen fibers and crystal growth within 
osteoid and predentin. Most of the phosphoproteins are SIBLINGs (Small Integrin-
Binding Ligand, N-linked Glycoproteins), genes of which are on the same 
chromosome. The polyanionic SIBLINGs all interact with collagen fibrils and can be 
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cleaved into small fragments by enzymes. The posttranslational modifications, such 
as phosphorylation, binding and fragmentation may affect mineralization [11. C. Qin, 
O Baba, 2004].  
 The SIBLING proteins include osteopontin (OPN), bone sialoprotein (BSP), 
dentin matrix protein 1(DMP1), dentin sialophophoprotein (DSPP), and matrix 
extracellularphosphoglycoprotein (MEPE).    
Osteopontin (OPN) is a secreted 60-kDa phosphoprotein. The name was 
introduced to reflect the potential function in bone to serve as a bridge between 
cells and hydroxyapatite through RGD and polyaspartic acid motifs. OPN is present 
in bone in large quantities, but it is also expressed in a variety of tissues and cells 
[11. C. Qin, O Baba, 2004]. Several animal studies show that OPN may be a major 
inhibitory factor on mineralization [66. Boskey AL, Spevak L, 2002] and its 
deficiency affects the function of osteoclasts [67. Razzouk S, Brunn JC, 2002]. 
 BSP (Bone sialoprotein), unlike OPN, is found almost exclusively in mineralized 
tissues including bone, dentin, mineralizing cartilage, and cementum. Analysis of 
some data suggests that BSP acts as a nucleator of the initial apatite crystals, and 
then acts as inhibitor in directing the growth of the crystals [11. C. Qin, O Baba, 
2004]. Adult mice with a knockout of the Ibsp gene (Bsp-/-) are shorter than their 
wild type counterparts and display a low level of bone remodeling [87. Malaval L, 
Wade-Gueye NM, 2008]. Another study further showed that Bsp-/- mice are born 
with their shorter stature and that the lack of Bsp alters long bone growth, 
membranous/cortical primary bone formation and mineralization, as well as 
cartilage and osteoblast gene expression, with low bone Igf-1 and high levels of 
Opn [88. Wafa Bouleftour, Maya Boudiffa, 2014 ]. 
DMP1(dentin matrix protein 1) is found in dentin, bone and soft tissue. It 
plays an important role in mineralization of bone and dentin supported by many 
studies [89. Shigeki Suzuki, Naoto Haruyama, 2012]. MC3T3-E1 cells 
overexpressing DMP1 showed earlier onset of mineralization and produced 
mineralized nodules [90. Narayanan K, Srinivas R, 2001]. Dmp1 knockout mice 
showed delayed conversion of osteoid to bone and predentin to dentin [91. Feng 
JQ, Ye L, 2002.11. C. Qin, O Baba, 2004]. The full length form of DMP1 inhibits 
calcification, but becomes a promoter of calcification when cleaved or 
dephosphorylated [31.Tartaix et al(2004)].  
Dentin sialophophoprotein (DSPP), the precursor protein, gives rise to two 
proteins, dentin sialoprotein (DSP) and dentin phosphoprotein (DPP). DPP is the 
most abundant NCP in the ECM of dentin. It contains large amounts of aspartic acid 
and phosphoserine. DPP is an important initiator and modulator of dentin apatite 
crystal formation. Dspp knockout mice show defective mineralization of dentin. 
DSPP is present not only in teeth but also in bone and osteoblasts but a much lower 
levels than in teeth [11. C. Qin, O Baba, 2004]. 
MEPE (Matrix extracellular phosphoglycoprotein) is an inhibitor of 
mineralization is situ. MEPE exists as smaller peptides, including the C-terminal 
ASARM (acidic, serine-, and aspartic acid-rich MEPE motif) peptide, which is 
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analogous to the C terminus of the salivary protein statherin. In bone, MEPE is 
mainly expressed by osteocytes [12. Adele L. Boskey,2010]. 
 
Differences in collagen between skeletal and nonskeletal tissues  
 
Skeletal tissues 
 
The intra- and intermolecular crosslinks show a highly specific molecular packing 
arrangement in the fibril and tissue specificity. One of the most well-investigated 
pathways is the one leading to a Pyr(pyridinoline) crosslinks. It starts with the Hylald 
residue in the telopeptides, which then reacts with the neighboring helical 
hydroxylysine residue producing an intermolecular aldimine cross-link. The aldimine 
can rearrange to form a ketoamine form. Both forms are reducible with reducing 
agents and can condense with each other forming a trifunctional cross-link, Pyr. A 
pyrrolic compound is a trifunctional maturation product of the ketoimines. Pyrrole 
cross-links appear to be restricted to bone and high-load tendons [13. David R. Eyre, 
Mary Ann Weis, 2013, 9. Mitsuo Yamauchi, Marnisa Sricholpech, 2012 ] . The 
pyrrole cross-link is of greater biomechanical importance than the pyridinoline 
cross-links in mature bone, more amount of pyrrole correlated with higher bone 
strength [14. L.Knott, A.J.Bailey,1998 ]. Pyridinoline and pyrrole are predominant in 
skeletal tissues. Although Pyr is present in most skeletal and connective tissues, 
such as cartilage, bone, dentin, tendon, aorta and ligament, it is almost absent from 
skin and cornea.  
 
(a.)                                     (b.)                                             (c.) 
                                          
Illustration 1. Structures of pyridinoline and pyrrole cross-links. (a.) The 
structure of hydroxylysyl pyridinoline (HL-Pyr) cross-link. (b.) The structure of lysyl 
pyridinoline (L-Pyr) cross-link (C.) The structure of pyrrole cross-link. (Adopted from 
L.Knott et. al. Bone.1998) 
 
Non-skeletal tissues 
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HHL (histidinohydroxylysinonoleucine) is predominant in skin and cornea and are 
suitable for these two tissues because it is a more UV-resistant stable tri-functional 
cross-link. The major cross-link in soft-tissue is derived from an ACP(aldol 
condenstation product) which can further condense with hydroxylysine forming an 
aldimine bond. This cross-link, which involves four amino acids, has the most 
complex chemical structure in all of the known collagen crosslinks. [9. Mitsuo 
Yamauchi, Marnisa Sricholpech, 2012 ].  
 
In mineralizing tissues, bone specific lysyl pyridinoline and pyrolic cross-links are in 
a large amount. The collagen post-translational modifications appear to play an 
integral role in matrix mineralization. Disturbances in the post-translational 
modification of collagen can affect the mineralization density and crystal structure of 
the tissue [14. L.Knott, A.J.Bailey,1998 ] 
 
Mechanism of mineralization of hard tissues 
 
The mechanism of mineralization in bone and other hard tissues is still 
uncertain. While investigators in the one-mineralization field are divided between 
accepting collagen-mediated and matrix vesicle mediated mechanisms of 
mineralization, there is no obligatory incompatibility between these two mechanisms. 
Matrix vesicle-mediated and collagen-mediated models of mineralization are two 
separate, but linked steps during osteogenesis and dentinogenesis [15. Marc 
D.McKee, Betty Hoac,2013].  
Matrix vesicles are formed and released from the outer membranes of 
osteoblasts and related cells. It is believed that HA is first nucleated within the 
vesicle. As the crystallite grows bigger, it breaks through the vesicle and is exposed 
to the extracellular fluid.Extravesicular mineralization is then driven by the 
extracellular phosphate: pyrophosphate ratio and by the presence of a collagenous 
fibrillar scaffold, with further regulation of crystal growth by noncollagenous proteins 
of the small integrin-binding ligand N-linked glycoprotein family[15. Marc D.McKee, 
Betty Hoac,2013, 7. Liam C. Palmer, Christina J. Newcomb, 2008].  
According to the theory,the initial mineral formation (phase 1) is under 
cellular control, whereas mineral propagation (phase 2) is mediated by collagen in 
the extracellular matrix. The hole zones of collagens are critical in mineralization, as 
they appear to be the site of mineral nucleation. The crystals appear to grow and 
proliferate from this area. The size of this gap also appears to constrain the mineral 
growth. In fact, matrix vesicles are not the only site of mineral nucleation. Numerous 
studies have shown that a wide variety of matrix proteins can also nucleate and 
control the growth or agglomeration of these crystals [15. Marc D.McKee, Betty 
Hoac, 2013, 7. Liam C. Palmer, Christina J. Newcomb, 2008]. 
 The biologic control regulating crystal growth in mineralized tissues appears 
to control the level of mineral-nucleating and mineral-inhibiting noncollagenous 
proteins to transform unmineralized matrix into mineralized matrix. Many of the 
noncollagenous proteins are highly acidic phosphoproteins that bind strongly to 
mineral to regulate crystal growth. Small integrin-binding ligand N-linked 
glycoproteins are associated with specific sites on collagen molecules, possibly to 
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promote the nucleation and growth of apatite crystals related to collagen [16. Traub 
W, Arad T, weiner S.,1992, 15. Marc D.McKee, Betty Hoac, 2013]. 
 
 
Mechanism of maintaining unmineralized in saliva and periodontal ligament 
 
Calcium and inorganic phosphate ions are essential to hard tissue formation 
since they are the components of crystals. Phosphoproteins/phosphopeptides with 
clusters of acidic residues aid in the prevention of unwanted precipitation of solid 
calcium phosphates. The acidic residues, particularly phosphoserine, interact with 
calcium and stabilize clusters of calcium and phosphate. Statherin and acidic 
proline-rich proteins in saliva have a distinct similarity of structure, with all 
containing clusters of negatively charged residues such as phosphoserine, 
glutamate and aspartate. These residues interact with calcium and phosphate ion 
clusters to stabilize them in aqueous environments, that is, inhibiting precipitation 
and crystal growth of hydroxyapatite from supersaturated solutions of calcium 
phosphate [17. Cochrane NJ, Cai F, 2010, 18. Cochrane NJ, Reynolds, 2012,19. 
Raj PA, Johnsson M,1992 ]. 
Evidence shows that cells in the periodontal ligament secrete molecules to 
regulate the extent of mineralization and prevent the fusion of tooth root with 
surrounding bone, e.g. ankylosis [ 1. Antonio Nanci, Dieter D. Bosshardt, 2006, 20. 
Michele M. Fong, M. Ali Darendelier, 2007]. Balancing between the activities of 
bone sialoprotein and osteopontin may play a role in establishing and maintaining 
an unmineralized periodontal ligament region. Matrix ”Gla” protein is an inhibitor of 
mineralization (See below). Matrix Gla protein also may function to preserve the 
periodontal ligament width. It has been reported that Msx2 prevents the osteogenic 
differentiation of periodontal ligament fibroblasts by repressing Runx2 transcriptional 
activity and may play a vital role in preventing ligaments and tendons, in general, 
from mineralization [21. Yoshizawa T, Takizawa F, 2004]. It also been claimed that 
glycosaminoglycans [22. Kirkham J, Brookes SJ,1995] or RGD-cementum 
attachment protein [23. Ohno S, Doi T, Fujimoto K, 2002] may also play a role in 
maintaining the unmineralized state of the periodontal ligament.  
  A novel protein, follicular dendritic cell secreted protein (FDC-SP) has been 
identified in human periodontal ligament. FDC-SP is not PDL specific. It is a small 
secreted protein of unknown function expressed in human tonsillar germinal centers. 
FDC-SP may function in part by regulating B cell chemotaxis and be a regulator of 
B cell responses [24. Monther Al-Alwan, Qiujiang Du,2007].  The molecular 
properties, organization and function of FDC-SP are very similar to statherin, which 
plays an important role in the inhibition of spontaneous precipitation of calcium salts 
in saliva [25. Sayaka Nakamura, Tatsuo Terashima, 2005]. Recent study shows that 
FDC-SP is a negative regulator of PDL cell differentiation into osteoblastic cells and 
maintains the PDL fibroblastic phenotype, which may be through an EGFR pathway 
[5. Na Wei, Haiyang Yu, 2011]. It has also been proven that FDC-SP 
overexpression inhibits osteogenic differentiation of human periodontal ligament 
cells [26. Xiang L, Ma L, He Y, 2013]. 
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Inhibitors of mineralization 
 
Soft tissues do not normally mineralize under a phisiological condition, partly 
because they lack an abundant scaffolding ECM and consist mostly of cells or 
because potent mineralization-inhibiting molecules may be present when ECM is 
present [27. Schinke T, McKee MD, 1999 ]. 
Vitamin K-dependent carboxylation/γ-carboxyglutamic (GLA) domain is a 
protein domain that contains post-translational modifications of many glutamate 
residues by vitamin K-dependent carboxylation to form γ-carboxyglutamate (Gla). 
Proteins with this domain are known as Gla-proteins. Gla-proteins are mainly found 
in blood plasma and calcified tissues, like bone and dentin. Blood coagulation 
proteins are Gla-proteins in blood plasma. Matrix Gla protein and osteocalcin are 
two Gla-proteins found in bone with sufficient amount. The Gla residues have high-
affinity of binding to calcium ions. [57. Vermeer,1990] 
 
Matrix Gla protein (MGP) 
 
MGP is a 14-kDa ECM protein which contains 4 γ-carboxylated glutamic acid (Gla) 
residues in mice. It is originally isolated from bone and may also result from 
cartilage and blood vessels. Mgp-deficient mice show two major phenotypic 
abnormalities: extensive mineralization of the ECM in arteries, and premature 
mineralization of cartilage, supporting that MGP functions as a potent mineralization 
inhibitor in blood vessels and cartilage [ 28. Luo G, Ducy P, 1997, 29. N.R.Kaipatur, 
M. Murshed,2008].  
Another study of transgenic mice expressing MGP ectopically in bones and teeth 
show extensive hypomineralization, which is four to eight-fold higher than wild-type 
tissues. This result also strengthen the view that physiologic mineralization of bone 
and tooth ECMs is critically regulated by potent mineralization inhibitors [ 29. 
N.R.Kaipatur, M. Murshed,2008]. 
 
Osteocalcin (OC) 
 
OC is the most abundant noncollagenous protein in bone. OC needs calcium to 
associate with the ECM and the calcium can trigger its conformational change. The 
known functions of OC are to inhibit hydroxyapatite nucleation and activate mature 
osteoclasts. OC is a potent chemoattractant to osteoclast precursors [30. Hauschka, 
P.V., Lian, B.J., 1989, 31. Daniel L. Coutu, Jian Hui Wu,2008]. 
 
Blood coagulation proteins 
 
Blood coagulation proteins, such as prothrombin (factor II), factor VII, IX, and X, the 
anticoagulant proteins C and S, contain Gla domain and play a role in coagulation 
[57. Vermeer, 1990]. MGP and osteocalcin are both calcium-binding proteins that 
may participate in the organization of bone tissue. Both have glutamate residues 
that are post-translationally carboxylated by the enzyme gamma-glutamyl 
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carboxylase in a reaction that requires Vitamin K hydroquinone. This process also 
occurs with a number of proteins involved in coagulation: prothrombin, factor VII, 
factor IX and factor X, protein C, protein S and protein Z [58. U Grober, J Reichrath, 
2014]. Increased carboxylation of vitamin K–dependent proteins within the arterial 
vessel wall suggests the presence of the more active coagulation factors. These 
proteins have been shown to be present in all stages of atherosclerosis [59. Henri, 
2006] 
Genetic disease 
 
One or more abnormalities in the genome may cause genetic diseases. 
Some genetic diseases are inherited and the mutated genes are passed down from 
their parents or ancestors. Some genetic diseases caused by new mutations or 
changes to the DNA, such as lifestyle and environmental factors, are not hereditary. 
There are many types of single gene disorders: autosomal dominant, autosomal 
recessive, X-linked dominant, X-linked recessive, Y-linked, and mitochondrial 
disorder.  
 
FAM20 family 
 
FAM20 (family with sequence similarity 20) members in humans consist of 
FAM20A, FAM20B and FAM20C. By database analysis with the mouse Fam20a 
sequence, Nalbant et al. (2005) identified a family of genes with related sequence 
that included 2 additional members in mammals, FAM20B and FAM20C. These 
proteins are highly conserved in human, mouse, and rat. All contain a conserved 
putative signal sequence and a conserved C-terminal domain (CCD). Expression 
analysis revealed that Fam20a, Fam20b and Fam20c were expressed during 
hematopoiesis. The FAM20 family represents a new family of secreted proteins with 
potential functions in regulating differentiation and function of hematopoietic tissues 
[63. Nalbant D, Youn H, 2005].  
FAM20A plays an important role in enamel development and gingival 
homeostasis. The mutations of FAM20A in humans lead to Amelogenesis Imperfect 
(AI), gingival hyperplasia and enamel renal syndrome (ERS) in humans. The 
deletion of Fam20a gene in mouse leads to AI and disseminated calcifications of 
muscular arteries and intrapulmonary calcifications [36. Vogel P, et al (2012) ]. 
FAM20A mutation can lead to AI with gingival fibromatosis syndrome [37. O’Sullivan 
J, et al. (2011). 38. Cho SH,et al.(2012).] and enamel renal syndrome [39. 
Jaureguiberry G,et al. (2012). 40. Wang SK, et al. (2013).]  
FAM20B is ubiquitously expressed and phosphorylates xylose within the 
tetrasaccharide linkage region of proteoglycans [41. Koike T, Izumikawa T, Tamura 
J.(2009)., 56. Jianzhong Wen, Junyu Xiao (2014)]. Mutations of FAM20B in Danio 
rerio result in decreased cartilage matrix production and skeletal defects [42. Eames 
BF,et al.(2011)].  
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FAM20C has been shown to be a secreted, calcium-binding protein [65. Hao 
J, Narayanan K, 2007]. Mutations of FAM20C result in Raine syndrome, autosomal-
recessive disorder. One of the mutants is D478A which indicates that aspartic acid 
at position 478 was replaced by alanine. Patients with Raine syndrome may display 
lethal osteosclerotic bone dysplasia characterized by generalized osteosclerosis, 
ectopic calcifications and characteristic facial features often die shortly after birth. 
The nonlethal patients, manisfesting bone sclerosis, hypophosphatemic 
rickets/osteomalacia may live into an adulthood [43. Takeyari S, Yamamoto T, 2014, 
44. Peihong Liu, Hua Zhang, 2014]. Few nonlethal cases have dental abnormalities, 
such as high palate, small teeth with enamel dysplasia,	and clinical features of 
hypophosphatemia [33. Simpson MA,et al. (2009). 45. Rafaelsen SH, et al. (2013). 
46. Junyu Xiao, Vincent S (2013). 34. Fradin M, Stoetzel C.(2010) ] . In Fam20C-
deficient mice, a remarkable loss of bone, cementum, along with inflammation of the 
periodontal ligament and formation of periodontal pockets were developed [44. 
Peihong Liu, Hua Zhang]. The phenotypes of these patients with mutated FAM20C 
indicate the important role of FAM20C in mineralization. 
The first reported case of Raine syndrome was presented in 1989; a female 
neonate, who died at the age of 86min [32. Raine J, Winter RM, 1989]. Kan and 
Kozlowski suggested the name of Raine syndrome to describe this new lethal 
osteosclerotic bone dysplasia. Since the first case reported in 1989 by Raine et al., 
23 cases have been published. All the cases described were lethal during the 
neonatal period except for the last two reported patients, aged 8 and 11 years [33. 
Simpson MA, et al., 2009] and two sisters, aged 1and 4 years [34. Fradin M, 
Stoetzel C, Muller J, 2010]. Individuals with lethal osteosclerotic bone dysplasia 
characterized by generalized osteosclerosis with periosteal bone formation. 
Affected individuals survive only days or weeks, with the cause of death most 
commonly reported as respiratory failure, which may be due to thoracic 
malformation. Radiography shows that generalized increase in the density of all 
bones and obvious increase in the ossification of the skull and facial bones. The 
ossification leads to characteristic facial features, including narrow prominent 
forehead, proptosis of the eyes, depressed nasal bridge, and mid-facial hypoplasia. 
The periosteal bone formation, which differentiates the Raine syndrome from 
osteopetrosis and other known osteosclerotic dysplasias, is also characteristic of 
this disorder [35. M. A. Simpson, R. Hsu, 2007]. The two nonlethal patients reported 
in 2009 presented severe mental retardation, whereas the other two nonlethal 
sisters reported in 2010 presented unexpectedly normal psychomotor development 
at ages 4 and 1. Identification of mutations in nonlethal patients confirms a broader 
phenotypic spectrum. The survival of these four patients may be due to milder 
underlying genotype or the more aggressive treatments they have received. These 
case reports motivated us to revisit FAM20 gene classification [33. Simpson MA, et 
al., 2009, 34. Fradin M, Stoetzel C, Muller J, 2010] 
Mutations of the FAM20C gene were identified in six subjects with lethal 
osteosclerotic bone dysplasia. Homozygous changes were identified in four 
subjects, three of whom were offspring of consanguineous unions and comprised 
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three nonsynonymous base changes (1093G→A [Gly365Arg], 112T→G [Leu374-
Arg], and 1603C→T[Arg535Trp]) and an intron 4/exon 5 acceptor splice-site change 
(c915-3C→G). Heterozygous changes were identified in two subjects. One 
heterozygous change was nonsynonymous base change (1094G→A [Gly365-Glu]) 
and an intron 7/exon8 acceptor splice-site change (c1322-2A→G). The other 
heterozygous change was the exon4/intron4 donor splice site (c914+5G→C) and 
the intron8/exon9 acceptor splice site (c1404-1G→A) [35. M. A. Simpson, R. Hsu, 
2007]. Mutations of FAM20C gene were also identified in four subjects with 
nonlethal osteosclerotic bone dysplasia. The two nonlethal patients with severe 
mental retardation, one was a homozygous nonsynonymous mutation in exon 
7(1309G>A D437N) and the other was heterozygous nonsynonymous mutation in 
exon 2(731T>A I244N) and in exon 3(796G>A G266R) [ 33. Simpson MA, et al., 
2009.] The newly discovered two nonlethal patients with normal psychomotor 
development was homozygous mutation in c.940C>T(p.P314S) [ 34. Fradin M, 
Stoetzel C, Muller J, 2010] 
 
 
Identification of FAM20C as the Golgi-casein kinase 
 
The discovery of protein phosphorylation was first reported over a hundred 
years ago by the characteristics of the milk protein Casein [60.Hammarsten 
O,1883 ]. Two families of expressed protein kinases have been termed Casein 
kinase1(CK1) and Casein kinase 2(CK2). However, Casein is a secreted protein 
whereas CK1 and CK2 are cytoplasmic and nuclear. CK1 and CK2 don’t contribute 
the phosphorylation of Casein. Golgi casein kinase (G-CK), first describing in 
lactating mammary glands, had been termed due to the contribution of endogenous 
Casein phosphorylation [61. Bingham EW, Farrel HM Jr, 1974]. 
Drosophila Four-jointed (Fj) was identified as the first molecularly 
characterized Golgi-localized protein kinase [62. Ishikawa HO, Takeuchi H, 2008]. 
The protein sequences related to Fj and its mammalian homologue, Fjx1. The 
closest homologues are encoded by Family with sequence similarity 20 (FAM20), 
which in humans comprises FAM20A, FAM20B, and FAM20C [63. Nalbant D, Youn 
H, 2005]. 
Golgi Casein kinase (G-CK) was first described in lactating mammary glands 
and has been enzymatically characterized. FAM20C was identified as the G-CK for 
the following evidence. First, FAM20C was present both in the medium and cell 
lysate confirmed with the Western blotting and exhibited extensive overlap with a 
Golgi marker by immunolocalization. It shows that FAM20C is a Golgi-localized 
protein. Second, the Km for ATP of FAM20C (78µM) is similar to G-CK (80µM)[61. 
Bingham EW, Farrel HM Jr, 1974]. Third, both of them have the ability to 
phosphorylate Casein. Furthermore, G-CK exhibits a preference for Mn++ over Mg++ 
as a cofactor, same as FAM20C [64. Bingham EW, Groves ML,1979 ]. FAM20C 
exhibited a strong activity on the G-CK peptide and only a very weak activity on the 
other CK1 and CK2 peptides, supporting its responsibility for G-CK activity. For the 
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above reasons, FAM20C is G-CK [47. Hiroyuki O.Ishikawa, 2012, 51. Vincent S. 
Tagliabracci et al., 2012	].    
 
 
FAM20C substrates 
 
FAM20C is the Golgi casein kinase that phosphorylates secreted 
phosphoproteins with Ser-x-Glu/pSer (S-X-E/pS) motifs. FAM20C substrates 
include both Casein and members of the SIBLINGs (small integrin-binding ligand, 
N-linked glycoproteins consisting of five identically oriented tandem genes clustered 
within an ~375 kb span of nucleotides on human chromosome 4) [47. Hiroyuki O. 
Ishikawa, Aiguo Xu, 2012. 70. Vincent S Tagliabracci , 2013 ] . As mentioned above, 
the SIBLINGs include osteopontin (OPN), bone sialoprotein (BSP), dentin matrix 
protein 1(DMP1), dentin sialophophoprotein (DSPP), and matrix 
extracellularphosphoglycoprotein (MEPE). Evidence has supported that the 
SIBLINGs have important roles in regulating HA formation in bone and dentin, 
implicating the role of FAM20C in biomineralization [15. Marc D.McKee, Betty 
Hoac,2013, 7. Liam C. Palmer, Christina J. Newcomb, 2008, 70. Vincent S 
Tagliabracci , 2013  ]. 
Many secreted proteins not highly related to biomineralization are also 
phosphorylated within S-X-E/pS motifs by FAM20C. The oocyte secreted factor, 
bone morphogenetic protein-15 (BMP-15) and growth and differentiation factor-9 
(GDF-9) are phosphorylated by FAM20C and the phosphorylation is essential for its 
bioactivity, such as folliculogenesis and ovulation in mammals [71. Elena Tibaldi, 
Giorgio Arrigoni, 2010, 70. Vincent S Tagliabracci , 2013]. Coagulation factor IX is 
phosphorylated in human plasma within an S-x-E motif, which is likely important for 
its physiological coagulation activity since the nonphosphorylated factor IX rapidly 
disappears from plasma [72. Hideko Atoda, Emi Yokota, 2006, 70. Vincent S 
Tagliabracci , 2013]. G-CK has been detected in the Golgi apparatus of a variety of 
tissues, and has been shown to phosphorylate substrates such as progastrin [73. 
Lasa-Benito M, et al.,1996. 74. Meggio F, et al. 1989.75, MeggioF, et al. 1988. 80. 
Dockray GJ, et al.1987], Adrenocorticotropic hormone, (ACTH, also known as 
corticotropin) [76. Lasa M, et al.1997. 77. Duncan JS, et al., 2000. 79. Bennett HP, 
et al.1981], IGF binding protein-1 [78. Dolcini L, et al., 2009]. Phosphorylation might 
play a role in the control of posttranslational processing of regulatory peptide 
precursors, like progastrin [80. Dockray GJ, et al.1987], formation of ACTH [79. 
Bennett HP, et al.1981], and the propensity of IGF binding protein-1 to proteolysis 
[78. Dolcini L, et al., 2009]. Fam20C will likely have many substrates in addition to 
proteins involved in biomineralization [70. Vincent S Tagliabracci , 2013]. 
Phosphorylation of OPN occurs mainly on serine residues and is principally 
catalyzed by casein kinases. OPN has a high level of serine conservation and half 
of the conserved serine residues are potential phosphorylation sites for casein 
kinases I and II. Phosphorylation of OPN is essential for its inhibitory role on 
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mineralization [66. Boskey et al, 2002]. Studies showed that phosphates on OPN 
may be involved in regulating the resorptive activity of osteoclasts [67. Razzouk et 
al, 2002. 11. C. Qin, O Baba, 2004]. 
Phosphorylation in BSP, like OPN, occurs mostly at serine residues. Human 
BSP contains 5 phosphates, 4 of which are located in the central region of its 
primary sequence. Removal of the phosphates has no apparent influence on the 
ability of BSP to promote crystal formation, but they may affect crystal growth [68. 
Hunter and Goldberg,1994. 11. C. Qin, O Baba, 2004].  
DMP1 has 65 Ser/thr that are potential casein kinases I and II 
phosphorylation sites. Although the functions of phosphates on DMP1 are unknown, 
they may serve as sequestering groups for recruiting calcium ions, similar to the 
roles of phosphates on DPP [11. C. Qin, O Baba, 2004]. 
DPP, derived from DSPP, is the most abundant NCP in dentin and is highly 
phosphorylated. About 45% of the total sequences is serine residues and most of 
them are phosphorylated. The large number of phosphates is vital to the functions 
of DPP. Removal of phosphate groups results in the loss of its role in the nucleation 
of apatite onto collagen [69. Saito et al.,1997. 11. C. Qin, O Baba, 2004]. 
MEPE (Matrix extracellular phosphoglycoprotein) is regulated by 
posttranslational modifications. The phosphorylated protein is an effective promoter 
of mineralization, while the associated ASARM peptide (acidic serine-aspartate-rich 
MEPE-associated motif) is an effective inhibitor [12. Adele L. Boskey, 2010].  
FAM20C substrates are highly expressed in bone and teeth and their ability 
to modulate mineralization possibly depending on their phosphorylation status [2. 
Anthony Palumbo. 47. Hiroyuki O. Ishikawa, Aiguo Xu(2012)] . 
 
 
2. Materials and methods 
 
Reagents 
 
! Human embryonic kidney 293 cells were purchased from Clontech (Mountain 
View, CA, USA).  
! Cells were maintained in Dulbecco's Modified Eagle Medium (DMEM) (1X), 
liquid (4.5 g/L D-Glucose,L-Glutamine,110mg/L Sodium Pyruvate) purchased 
from Life Technologies (Carlsbad, CA, USA).  
! Penicillin and streptomycin mixture was added to DMEM medium using 
Penicillin-Streptomycin Solution, 100X, 10,000 I.U. Penicillin 10,000 µg/mL 
and Streptomycin purchased from Mediatech, Inc. (Manassas, VA., USA).  
! Fetal Bovine Serum which was purchased from Invitrogen (Carlsbad, CA, 
USA) and also added to DMEM. 
! Cells were detached from culture plates using Trypsin, 0.25% 1X, with 2.5g 
porcine trypsin (1:250/L gamma irradiated) in HBSS with 1g/L EDTA, without 
calcium, magnesium (liquid) purchased from Thermo Scientific (Waltham, 
MA, USA). 
! PMSF (phenylmethylsulfonyl fluoride) was purchased from MP Biomedicals. 
The stock concentration is 0.1M and the working concentration is 1mM. 
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! Anti-V5 antibody was purchased from Life-Technologies and protein A-
Sepharose 4B conjugated was from Life Technologies. 
! Anti-V5 AP antibody was purchased from Invitrogen. 
! Anti-FAM20C antibody was purchased from Sigma-Aldrich. 
! Rabbit IgG was purchased from Thermo Scientific. 
! SDS NuPAGE® MOPS SDS Running Buffer (for Bis-Tris Gels only) (20X) 
was purchased from Invitrogen (Carlsbad, CA, USA).  
! NuPAGE® Novex 4-12% Bis-Tris Gel 1.0 mm, 12 well purchased from 
Invitrogen (Carlsbad, CA, USA).  
! Immobilon-P Membrane purchased from Millipore (Billerica, MA, USA) was 
used to transfer western blot gel.  
! Nonfat dry milk was purchased from Lab Scientific (Livingston, NJ, USA). 
! Alkaline phosphatase conjugate substrate kit from Bio-Rad laboratories 
(Hercules, CA, USA).  
! Chemiluminescent HRP Antibody Detection Reagent was purchased from 
Denville Scientific Incorporation. 
! HyBlot CL autoradiography film was purchased from Denville Scientific 
Incorporation. 
! For purification of polyhistidine-containing recombinant proteins, Ni-NTA 
agarose was purchased from Qiagen and columns was purchased from Bio-
Rad.  
! For dialysis, Float-A-Lyzer was purchased from Spectrum Laboratories,Inc. 
! Coomassie brilliant blue (CBB R-250) was purchased from Bio-Rad. 
! Western Blot Stripping Buffer was purchased from Thermo Scientific. 
 
Buffers 
 
! Lysis buffer containing 150mM NaCl, 20mM Tris-HCl (pH7.5), 10mM EDTA, 
1% Triton-X 100 and 1% deoxycholate was prepared.  
! Transfer buffer containing 0.025M Tris-HCl (pH 8.3), 0.192M glycine, and 
20% methanol was prepared. 
! For purification of polyhistidine-containing recombinant proteins, stock 
solution A (10X) containing 200mM sodium phosphate, monobasic 
(NaH2PO4) and 5M NaCl was prepared. Stock solution B (10X) containing 
200mM sodium phosphate, dibasic (Na2HPO4) and 5M NaCl was prepared. 
200 ml of 5x Native purification buffer was prepared with 7 g monobasic 
sodium phosphate, 29.2g NaCl and deionized water. One hundred ml of 3M 
Imidazole was prepared with 20.6g Imidazole, 8.77 ml stock solution A (10X) 
and 1.23 ml stock solution B (10X) and deionized water, adjusted the pH to 
6.0. 
! 50 ml Native Wash Buffer containing 50 ml of 1X Native purification buffer 
and 335 µl of 3M Imidazole, pH6.0 was prepared. 
! 15 ml Native Elution Buffer containing 13.75 ml of 1X Native purification 
buffer and 1.25 ml of 3M Imidazole, pH6.0 was prepared. 
! Tris-buffered saline (TBS) (1X) containing 20 mM Tris (pH 7.5) and 137 mM 
NaCl was prepared. 
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! SDS-Sample buffer containing 100 mM Tris-HCl (pH8.8), 0.01% 
bromophenol blue, 36% glycerol and 4% SDS was prepared. 
! CBB staining buffer containing 45% methanol,10% glacial acetic acid, 45% 
water and 3 g/L of Coomassie Brilliant Blue R250 
 
 
Plasmid construction 
 
Human FAM20C expression vector constructs including wild-type (WT) and a 
mutant form lacking its kinase activity (D478A, {Tagliabracci, 2012 #213}) 
expression vector were generated by PCR methods. The plasmids containing full 
length of coding sequence for human FAM20C was purchased (Open Biosystems) 
and used as PCR template. The sequences of the primers were as follows; (for 
FAM20C-WT) forward primer: 5’-GCGGTACCGCCATGAAGATGATGCTGG-3’ and 
reverse primer: 5’-GCCTCGAGCCTCGCCGAGGCGGCTCTG-3’, (for FAM20C-
D478A) mutagenesis forward primer: 5’-CACTTAGCCAATGGAAGAGGG-3’ and 
mutagenesis reverse primer: 5’-CCCTCTTCCATTGGCTAAGTG-3’. The PCR 
products of each FAM20C form were ligated into pcDNA3.1-V5/His mammalian 
expression vector, sequenced and the plasmids harboring FAM20C-WT and 
FAM20C-D478A cDNAs followed by V5/His- (pcDNA3.1-FAM20C-WT-V5/His and 
pcDNA3.1-FAM20C-D478A-V5/His) were successfully generated. 
 
Cell Culture 
 
Human embryonic kidney (HEK) 293 cells were maintained in DMEM 
containing a high concentration of glucose (4.5 mg/ml), supplemented with 10% 
fetal bovine serum, 100 units/ml penicillin, 100 µg/ml streptomycin in a 5% CO2 
atmosphere at 37 oC. 
 
Transfection to generate FAM20C-stably transfected clones 
 
HEK 293 cells were plated onto 6-well culture plates at a concentration of 3 
x105 cells / well. On the following day, 293 cells were transiently transfected in 
duplicate using X-treme GENE 9 DNA transfection reagent (Roche applied 
sciences) with pcDNA3.1-empty-V5/His, pcDNA3.1- human FAM20C-WT-V5/His 
and pcDNA3.1- human FAM20C-D478A-V5/His according to the manufacturer’s 
protocol. 
 
Immunoprecipitation and Western Blot (WB) Analysis 
 
After 24 hours of transfection, the transfected HEK 293 cells were lysed 
using lysis buffer and the cell lysates were collected. Cellular debris was removed 
by centrifugation at 12,000 rpm for 5 min at 4 °C and the supernatant was collected. 
Anti-V5 antibody was added to each lysate sample for immunoprecipitation (1:500) 
overnight at 4 °C. On the following day, 25ul of protein A-Sepharose 4 B conjugate 
was added to each immunoprecipitated sample and samples were further incubated 
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for 30 minutes at 4 oC with gentle rocking. Samples were then centrifuged, the 
supernatant was discarded and beads were washed with lysis buffer twice. 
Proteins bound to the beads were solubilized in SDS sample buffer, 
separated by SDS-polyacrylamide gel electrophoresis using NuPAGE® Novex® 4-
12% Bis-Tris Gels. Proteins were then transferred to Immobilon-P membrane in 
transfer buffer using Mini-PROTEAN® Tetra Cell system at 50 volts for 2 hours. The 
membrane was blocked with 10% skim milk in TBS overnight at 4 oC. The 
membrane was then washed 3 times with TBS and incubated with anti-V5 AP 
antibody (1:2000) overnight at 4 oC . The membrane was washed 3 times with TBS 
and the proteins of interest, FAM20C-WT and FAM20C-D478A, were visualized 
using alkaline phosphatase conjugate substrate kit. 
 
Generation of stable FAM20C-WT and FAM20C-D478A-overexpressing clones 
 
The transfected HEK 293 cells were trypsinized from one confluent well of a 
6-well plate and replated onto 15 cm culture dishes. Four hundred µg/mL of G418 
neomycin analogue was added on the following day and the cells were further 
cultured. Ten single colony-derived clones transfected with either FAM20C-WT or 
FAM20C-D478A were isolated, transferred to 24-well culture plates and further 
cultured. Cells were expanded and replated to 6-well plate. Once cells became 
confluent , two ml of CM was collected and immunoprecipitated with anti-V5 
antibody. WB with anti-V5 AP antibody for each clone was performed. The clones 
were chosen with stonger bands of interest by WB. The following clones, empty 
vector(EV)-clone #5, FAM20C-WT-clone #4, and FAM20C-D478A –clone #2 were 
further cultured in a larger scale for protein production. 
 
Purification of FAM20C proteins from conditioned media using Ni-NTA purification 
system 
The clones were grown on ten of 15 cm culture plates and three of 10cm 
culture plates, and the conditioned media of FAM20C-WT and FAM20C-D478A 
were collected. The conditioned media were centrifuged at 1,500 rpm for 5 min to 
remove any floating/dead cells and the aliquot was made into several 50 ml tubes. 
The total volume of each media collected was around 450 ml, thus 9 tubes. Then, 
500 µl of Ni-NTA agarose was added to each 50 ml tube and incubated overnight at 
4 °C. After incubation, the conditioned media were poured into the columns to trap 
the agarose beads and washed with 500 ml of native wash buffer. Proteins were 
then eluted into 22 fractions by 1.7 ml of native elution buffer for each fraction.  
Forty µl of the eluted sample from each fraction was taken, mixed with SDS sample 
buffer, applied to SDS-PAGE, and Western blotting was performed with anti-V5 AP 
antibody to identify the positive fractions. 
After the fractions with FAM20C expression performed by Western Blotting 
were identified, these fractions were combined and dialyzed against distilled water 
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using Float-A-Lyzer for 3 days at 4 °C. Distilled water was changed twice a day. 
After dialysis, samples were lyophilized and resuspended in distilled water. The 
protein concentration was measured and the purified protein was kept at -20 °C until 
use. Purified proteins were taken and Western blotting was performed with anti-V5 
AP antibody and anti-FAM20C antibody. 
Purification of FAM20C proteins from cell lysates using Ni-NTA purification system 
The clones were grown on ten of 15 cm culture plates. The cell pellets of 
FAM20C-WT and FAM20C-D478A were collected after trypsin treatment and stored 
at -20 °C until use. Forty ml of Native Binding Buffer (1x Native purification buffer) 
with protease inhibitors was used to resuspend cells from one 15cm dish. Cells 
were frozen at -20 °C and thawed at room temperature for two cycles. Cells were 
then sheared by passing the preparation through 16-gauge needle four times. The 
cell lysates were centrifuged at 3,000 rpm for 15 min and the supernatant was 
transferred to new tubes. Then, 400 µl of Ni-NTA agarose was added to each 40 ml 
of the clear supernatant and incubated overnight at 4 °C. After incubation, the 
lysates were poured into the columns and washed with 500 ml of Native Wash 
Buffer. Proteins were then eluted into 15 fractions by 1ml of Native Elution Buffer for 
each fraction. Forty µl of samples from each fraction were taken, mixed with SDS 
sample buffer, applied to SDS-PAGE, and Western blotting was performed with 
anti-V5 AP antibody to identify the positive fractions. 
Expression of purified FAM20C proteins from conditioned media and cell lysates  
After the protein concentration was measured with each type of FAM20C 
proteins derived from conditioned media or cell lysates (i.e. FAM20C-WT from 
conditioned media or lysates, FAM20C-D478A from conditioned media or lysates), 
various amounts of FAM20C-WT or FAM20C-D478A from conditioned media and 
cell lysates were prepared to quantify their expression levels. Purified proteins were 
prepared with SDS sample buffer, applied to SDS-PAGE. The expression levels 
were verified by Western blotting using anti-V5 antibody. 
 
Protein identification by Mass Spectrometry (MS) analysis 
 
Various amounts of purified FAM20C-WT (2.5, 5 and 7.5 µg) and FAM20C-
D478A (10 and 15 µg) proteins were prepared and applied to the SDS-PAGE. After 
the gel electrophoresis, the gel was stained with Coomassie Brilliant Blue (CBB). 
CBB staining positive bands were cut into segments. The segmented gels were 
sent to Taplin Mass Spectrometry Facility at Harvard Medical School for protein 
identification analysis.  
 
Binding of FAM20C-V5 to periostin 
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The mammalian expression vector constructs of mouse periostin with C-
terminal HA tag (pCAGI Puro delta periostin (b-)-WT-HA (periostin-WT), pCAGI 
Puro delta periostin-delta-CTR-HA(periostin-dCTR-HA), pCAGI Puro delta periostin-
delta-EMI-HA (Periostin-dEMI-HA), pCAGI Puro delta periostin-delta-EMI-CTR-HA 
(periostin-dEMI-CTR-HA) were kindly provided by Dr. Akira Kudo (Tokyo Institute of 
Technology, Japan). 
 
Illustration 2. Domain structures of intact and domain deletion forms of 
periostin. There were three deletion forms of periostin. CTR was cleaved as delta 
CTR. EMI was cleaved as delta EMI. EMI and CTR were cleaved as delta EMI CTR. 
(Adopted from Kii et. al. J. Biol.Chem. 2010) 
HEK 293 cells were plated onto 6-well culture plates at a concentration of 3 
x105 cells / well. On the following day, cells were transiently transfected in duplicate 
using X-tremeGENE 9 DNA transfection reagent with an empty vector (EV) of 
pcDNA3-3’-HA, periostin-WT-HA, periostin-dCTR-HA, periostin-dEMI-HA, periostin-
dEMI-CTR-HA and FAM20C-V5. After 24hours of transfection, cell lysates and 
conditioned media were collected. Twenty µl of lysates were taken, and conditioned 
media or the rest of lysates was immunoprecipitated (IP) with anti-V5 antibody. 
Western blotting (WB) using anti-HA antibody was performed to all samples from 
lysates with IP, lysates without IP, and conditioned media with IP. The membrane of 
lysates with IP was then stripped by stripping buffer and WB with anti-V5 antibody 
was performed to verify the expression of FAM20C. 
 
 
3. Results 
 
The goal of the study was to purify the FAM20C protein and then to find its binding 
proteins. The hypothesis was that FAM20C protein has post-modification, such as 
glycosylation. 
 
Protein sequence of FAM20C-WT and FAM20C-D478A with V5 tag was shown in 
Fig. 1. 
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Transfection to generate FAM20C-stably transfected clones 
 
To identify the binding proteins of FAM20C, FAM20C stably transfected 
clones were first generated. HEK 293 cells were selected for their higher 
transfection efficiency and transfected using X-tremeGENE 9 DNA transfection 
reagent with EV, FAM20C-WT and FAM20C-D478A. It was transfected in duplicate. 
One was lysed for the protein verification and the other was lysed for further culture 
to 15cm-plates. The lysates was collected and immunoprecipitated (IP) with anti-V5 
antibody. To determine whether the transfection with FAM20C-V5 was successful, 
Western blot analysis with anti-V5 antibody was performed. The expression of 
FAM20C-WT (Fig. 2, lane 2) and FAM20C-D478A (Fig. 2, lane 3) was confirmed by 
Western blot analysis. 
 
Cell cloning 
 
To clone a single cell-derived population of either FAM20C-WT or FAM20C-
D478A transfected cells, the transfected HEK 293 cells were trypsinized from 1 
confluent well of 24-well plate and replated onto 15 cm culture dishes. Ten single 
colony-derived clones transfected with either FAM20C-WT or FAM20C-D478A were 
isolated and transferred to 24-well plates. WB with anti-V5 AP antibody for CM of 
each clone was performed. The clone that exhibited the strongest FAM20C 
expression among all ten clones was selected (Fig. 3A and 3B) and reconfirmed by 
another Western Blotting (Fig 3C.). The expected molecular weight of FAM20C is 
66 kDa. In the study, the main band of FAM20C-WT clone was located slightly 
lower than 100 kDa. The expression of Clone #4 was stronger than clone #1and #5. 
The main band of FAM20C-D478A was also located slightly lower 100 kDa. The 
expression of Clone #2 was stronger than clone #7 and #8. The following clones, 
empty vector (EV)-clone #5, FAM20C-WT-clone #4, and FAM20C-D478A –clone #2, 
were chosen (Fig 3C.). Extra bands around 170 kDa was both noted at FAM20C-Wt 
and FAM20C-D478A. 
 
Purification of FAM20C proteins from conditioned media using Ni-NTA purification 
system 
To obtain FAM20C proteins from conditioned media, Ni-NTA purification 
system was used. The conditioned media of FAM20C-WT and FAM20C-D478A 
were collected. Ni-NTA agarose (1/100 volume) was added to conditioned media 
and incubated overnight at 4 °C. The conditioned media was washed with Native 
Wash Buffer after poring into the columns. Proteins were eluted into fractions by 
Native Elution Buffer.  Sample from each fraction was taken and applied to SDS-
PAGE, and Western Blotting was done with anti-V5 AP antibody. Immunoreactive 
bands to anti-V5 antibody were detected at around 100 kDa, which is the expected 
size of FAM20C, and 170 kDa in all fractions tested. Fraction 3 had the strongest 
expression compared with other fractions. In Fraction 3, one obvious 
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immunoreactive band is at around 100 kDa, and two additional bands are at 170 
kDa. No other obvious bands in each lane indicated successful purification by 
means of Ni-NTA purification system. Fractions containing FAM20C-WT and 
FAM20C-D478A were identified by WB analysis (Fig.4).  
In order to obtain FAM20C proteins, fractions positive for V5 antibody were 
combined and dialyzed against distilled water. After dialysis, samples were 
lyophilized and resuspended in distilled water. 
To further confirm the expression of the dialyzed and concentrated FAM20C 
protein samples, the protein concentration was measured, various amounts were 
taken, and analyzed by Western blotting (WB) using anti-V5 AP antibody and anti-
FAM20C antibody. The results that showed immunoreactive bands to anti-V5 
antibody were around 100 kDa and 170 kDa (Fig. 5, lanes 1 and 2).  These bands 
were also immunoreactive to anti-FAM20C antibody (Fig. 5, lanes 3 and 4). 
FAM20C-WT had stronger expression than FAM20C-D478A. The expression of 
FAM20C-WT and –D478A was confirmed by Western blotting with both anti-V5 and 
anti-FAM20C antibodies after purification (Fig. 5). 
 
Purification of FAM20C proteins from cell lysates using Ni-NTA purification system 
To obtain FAM20C proteins from cell lysates and compare them to the 
proteins from CM, Ni-NTA purification system was used. Cells were grown on ten of 
15 cm culture plates. The cell pellets of FAM20C-WT and FAM20C-D478A were 
collected with trypsin and resuspended in Native Binding Buffer with protease 
inhibitors. Cells were sheared by being frozen and thawed and by passing through 
16-gauge needle. The supernatant was transferred to new tubes after centrifugation. 
Ni-NTA agarose was then added to lysates and incubated. The lysates was then 
poured into the columns and washed with native wash buffer. Proteins were then 
recollected into 15 fractions by 1mL native elution buffer for each fraction.  Forty µl 
of sample from each fraction was taken, applied to SDS-PAGE, mixed with SDS 
sample buffer and Western Blotting was performed with anti-V5 AP antibody.  
Fractions containing FAM20C-WT and FAM20C-D478A were identified by 
WB analysis (Fig.6). The expression of FAM20C-WT of the later fraction was 
stonger than early ones. Fraction 13 had the strongest intensity of expression 
compared with earlier fractions. Fraction 3 of FAM20C-D478A had the strongest 
intensity of expression among all the fractions. The expression of FAM20C-D478A 
of the next fraction was weaker than the ealier ones. Compared the FAM20C 
proteins from cell lysates to the ones from conditioned media, three obvious 
immunoreactive bands to anti-V5 antibody, one around 100 kDa and the other two 
near 170 kDa, were still noted in cell lysates (Fig.3 and 5, arrows). Many 
immunoreactive bands to anti-V5 antibody ranging from 55 kDa to 130 kDa, were 
noted in lysate samples, much different from conditioned media samples (Fig.4 and 
6). 
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Expression of purified FAM20C proteins from conditioned media and cell lysates 
To obtain FAM20C proteins from cell lysates, all fractions with positive 
expression were combined and dialyzed against distilled water at 4 °C. After dialysis, 
samples were lyophilized and resuspended in distilled water.  
To further confirm and compare the expression of the purified FAM20C protein 
samples from conditioned media and cell lysates, the protein concentration was 
measured. Various amounts of the purified FAM20C proteins from conditioned 
media and cell lysates were taken and the expression was confirmed by Western 
blotting using anti-V5 antibody(Fig.7). Obvious immunoreactive bands to anti-V5 
antibody were clearly shown, indicating purification of FAM20C was achieved. Ten 
ng of purified FAM20C-WT protein from conditioned media was needed to be 
detected in the Western blot, while 0.4µg of purified FAM20C-WT protein from cell 
lysates was needed. Similarly, 75 ng of purified FAM20C-D478A proteins from 
conditioned media was needed to be detected in the Western blot, while 2.5 µg of 
FAM20C-D478A proteins from cell lysates was needed. FAM20C proteins were 
able to be collected from both purification methods. It also showed that FAM20C 
proteins were purified more easily from conditioned media than from lysates. 
Therefore, we decided to use FAM20C proteins from conditioned media (Fig.7).  
 
Protein identification by Mass Spectrometry (MS) analysis 
 
In order to examine the binding proteins of FAM20C, purified FAM20C-WT 
(2.5, 5 and 7.5 µg) and FAM20C-D478A (10 and 15 µg) proteins were prepared, 
electrophoresed, and the gel was stained with Coomassie Brilliant Blue (CBB). The 
CBB-positive bands were identified (see below), cut into segments, and these 
samples were sent to Taplin Mass Spectrometry Facility at Harvard Medical School 
for protein identification analysis. 
The gel stained by CBB showed three clear bands, one close to 85 kDa and 
the other two close to 170 kDa, in each lane (Fig.8, arrows). 
The data was analyzed after being filtered by the setting that Xcorr2 is 2.2 
and Xcorr3 is 3.5 [48. Ming Zhou et al.(2004)]. Analysis was performed by excluding 
the proteins located in cytoplasm first (Figs. 9-14).  
 
 FAM20C-WT  FAM20C-D478A 
Band 1 
(170 kDa upper 
band) 
FAM20C, 
HSPG2, 
TNC, 
FN1, 
IGHG1, 
ITIH2 
Band 4 
(170 kDa upper 
band) 
HSPG2,  
FAM20C,  
A2MG,  
TNC, 
FN1, 
PRP1,  
IGHG1, 
LAMB2, 
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NID2 
Band 2 
(170 kDa lower 
band) 
FAM20C, 
HSPG2,  
TNC, 
IGHG1, 
FN1, 
NID2 
Band 5 
(170 kDa lower 
band) 
FAM20C,  
HSPG2, 
A2MG, 
FN1, 
NID2, 
TNC 
Band 3 
(90~75 kDa) 
FAM20C, 
POSTN 
Band 6 
(85~75 kDa) 
FAM20C,  
HSPG2, 
PRP1,  
POSTN,  
ITIH2 
GRN 
 
Table 1. Protein identification by Mass Spectrometry (MS) analysis. The 
extracellular proteins that appeared most times in each segment were summarized. 
 
HSPG2, HEPARAN SULFATE PROTEOGLYCAN 2      
NID2, NIDOGEN 2 
LAMB2, LAMININ, BELTA-2 
A2MG, ALPHA-2-MACROGLOBULIN 
PRP1, PROLINE-RICH PEPTIDE-1 
POSTN, PERIOSTIN 
GRN, GRANULIN 
TNC, TENASCIN C 
FN1, FIBRONECTIN 1 
IGHG1, IMMUNOGLOBULIN HEAVY CONSTANT GAMMA1 
ITIH2, INTER-ALPHA-TRYPSIN INHIBITOR HEAVY CHAIN 2 
 
We first rule out the proteins that are localized in cytoplasm. Considering the 
number of unique peptides found by MS analysis, proteins with more than three of 
unique peptides are considered as the binding proteins. Proteins listed above are 
candidate FAM20C-binding proteins. According to the MS analysis, POSTN 
(periostin) is the only protein that found in band 3 and band 6. HSPG2 is present in 
all bands except band 3. It is known that HSPG2, NID2 and LAMB2 are basement 
membrane proteins. Besides periostin, HSPG2 and NID2, LAMB2, A2MG, PRP1, 
GRN, TNC, FN1, IGHG1 and ITIH2 were noted in band 4, 5 and 6. Since periostin 
is known to be a secretory protein and predominantly expressed in collagen-rich 
fibrous connective tissue and have several S-X-E motifs in their amino acid 
sequences, periostin may be one of the substrates of FAM20C [49. Russell A.Norris, 
Brook Damon, 2007, 44. Peihong Liu, Hua Zhang,2014 ]. Therefore, we decided to 
further investigate the association between FAM20C and POSTN. 
 
Binding of FAM20C to periostin (POSTN) 
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To verify the interaction between FAM20C and periostin, HEK 293 cells were 
transiently transfected with various forms of periostin-HA expression vectors and 
FAM20C-V5. Immunoprecipitation (IP)-Western blotting (WB) analyses were 
performed to identify the interaction between periostin and FAM20C from 
conditioned media. The expression of FAM20C-WT was confirmed by Western 
blotting with anti-V5 antibody (Fig.15B). The expression of periostin -HA was 
confirmed by Western blotting with anti-HA antibody (Fig.15D). 
 
In the presence of FAM20C-V5 (Fig.15A, lane 3, 7, 9,and 11), 
immunoreactive bands to anti-HA antibody were shown after IP with V5. periostin -
HA was expressed in the presence of FAM20C-V5, indicating that FAM20C 
associates with periostin. All forms of periostin, i.e. periostin -HA , periostin dCTR-
HA, periostin dEMI-HA and periostin dEMI -CTR-HA had strong expression in the 
presence of FAM20C-V5 after IP with V5. The results demonstrated that all forms of 
periostin bound to FAM20C in HEK293 cells. 
 
 
 
4. Discussion 
 
Protein identification by Mass Spectrometry (MS) analysis 
Proteins in the CBB gel were sent to Taplin Mass Spectrometry Facility at 
Harvard Medical School for protein identification analysis. The facility utilizes 
Orbitrap mass spectrometers from Thermo Scientific for high throughput analyses of 
gel bands. 
Mass spectrometers are used either to measure simply the molecular mass 
of a polypeptide or to determine additional structural features including the amino 
acid sequence or the site of attachment and type of posttranslational modifications. 
For simply measuring the molecular mass of a polypeptide, single-stage mass 
spectrometers are used, acting essentially as balances to weigh molecules. 
Tandem mass spectrometry (MS/MS) is commonly used in the product ion mode to 
determine the amino acid sequence of a specific peptide. For determining additional 
structural features, specific ions are selected and subjected to fragmentation 
through collision after the initial mass determination. Every mass spectrometry 
consists of three distinct stages. First, protein samples are isolated and optionally 
fractionated. The final protein sample is then digested and the resulting peptide 
sample is further fractionated.  Second, the peptides are subjected to qualitative 
and quantitative mass-spectrometric analysis. Finally, the large data sets generated 
are analyzed by suitable software tools to deduce the amino acid sequence. The 
peptide identity is assigned to the MS/MS spectra through database searching [50. 
Bruno Domon, Ruedi Aebersold,2006]. 
According to the MS analysis, FAM20C-WT is found in all samples, band 1, 2 
and 3. FAM20C-D478A is also found in all samples, band 4, 5 and 6. Ruling out the 
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proteins in cytoplasm and considering the number of unique peptides found by MS 
analysis, proteins with more than three of unique peptides are considered as the 
binding proteins. The possible FAM20C-binding proteins are POSTN (periostin), 
HSPG2, LAMB2, A2MG, PRP1, GRN, TNC, FN1, IGHG1 and ITIH2. 
HSPG2 protein is a large multidomain proteoglycan and a major component 
of basement membranes. HSPG2 plays an important role in maintaining endothelial 
barrier function and vascular homeostasis. It is also involved in the stabilization of 
other molecules and cell adhesion [ http://www.ncbi.nlm.nih.gov/gene/3339]. 
Nidogen protein is a basement membrane protein that binds collagens I, IV 
and laminin. Nidogen may be involved in maintaining the structure of the basement 
membrane [ http://www-ncbi-nlm-nih-gov.ezproxy.bu.edu/gene/22795]. 
Laminins are the major noncollagenous constituent of basement membranes. 
Laminins, composed of 3 non identical chains: laminin alpha, beta and gamma 
(formerly A, B1, and B2, respectively). Laminin, beta 2 has a more restricted tissue 
distribution. It is enriched in the basement membrane of muscles at the 
neuromuscular junctions, kidney glomerulus and vascular smooth muscle. 
Transgenic mice in which the beta 2 chain gene was inactivated, showed defects in 
the maturation of neuromuscular junctions and impairment of glomerular filtration 
[ http://www-ncbi-nlm-nih-gov.ezproxy.bu.edu/gene/3913]. 
Alpha-2-macroglobulin is a protease inhibitor. It inhibits many proteases, 
including trypsin, thrombin and collagenase. A2M can degrade A-beta, the major 
component of beta-amyloid deposits, and may play a role in Alzheimer disease 
[ http://www.genecards.org/cgi-bin/carddisp.pl?gene=A2M]. 
Proline-rich proteins are major components of parotid and submandibular 
saliva in humans and other animals. They can be divided into acidic, basic and 
glycosylated proteins. The acidic proline-rich proteins bind calcium strongly and 
may be important in maintaining the concentration of ionic calcium in saliva. Also, 
they can inhibit formation of hydroxyapatite, whereby growth of hydroxyapatite 
crystals on the tooth surface in vivo may be avoided [ 92. Bennick A, 1982].  
Granulins are a family of secreted, glycosylated peptides that are cleaved 
from a single precursor protein, progranulin. Cleavage of the signal peptide 
produces mature granulin which can be further cleaved into a variety of active 
peptides. The peptides and intact granulin proteins both regulate cell growth by 
inhibiting or stimulating. Granulin family members are important in normal 
development, wound healing, and tumorigenesis [ http://www-ncbi-nlm-nih-
gov.ezproxy.bu.edu/gene/2896] 
Tenascin C protein contains multiple EGF-like and fibronectin type-III 
domains. It is implicated in guidance of migrating neurons as well as axons during 
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development, synaptic plasticity, and neuronal regeneration 
[ http://www.ncbi.nlm.nih.gov/gene/3371 ] 
Fibronectin protein is involved in cell adhesion and migration processes 
including embryogenesis, wound healing, blood coagulation, host defense, and 
metastasis [ http://www.ncbi.nlm.nih.gov/gene/2335 ] 
The inter-alpha-trypsin inhibitors (ITI) are a family of structurally related 
plasma serine protease inhibitors involved in extracellular matrix stabilization and in 
prevention of tumor metastasis. The ITI family contains multiple proteins made up of 
a light chain and a variable number of heavy chains. ITIH2 stands for inter-alpha-
trypsin inhibitor heavy chain 2. [ http://www.ncbi.nlm.nih.gov/gene/3698 ] 
Periostin (POSTN) is a 90 kDa secreted protein. It is the first protein to be 
described with tissue specificity to the periosteum and the periodontal ligament. 
High levels of expression of periostin are observed in periosteum and periodontal 
ligament. The periostin may be secreted into the surrounding extracellular matrix 
possibly by osteoblasts, osteoblast precursors or periodontal fibroblasts. Periostin is 
mainly expressed in collagen-rich fibrous connective tissues, such as periodontium, 
periodontal ligament, aorta and heart valve. It appears to play an essential role in 
response to mechanical strains from physical exercise, mastication, blood flow and 
pressure. [53. Isao Kii, Takashi Nishiyama .(2010).] The localization of periostin is 
unique and no other glycoprotein has a similar distribution pattern. The expression 
of periostin is also regulated by TGF-β, functioning significantly on periosteal 
expansion and the recruitment of osteoblast precursors. Periostin has the potential 
to be a tissue-specific mediator of the effects of TGF-β on new bone formation and 
play a role in the recruitment and attachment of osteoblast precursors in the 
periosteum [54. Keisuke Horiuchi, Norio Amizuka.(1999)]. Periostin is found binding 
to type I collagen directly. Periostin null mice demonstrated a reduction in collagen 
fibril diameter in its skin resulting in a decrease in overall stiffness and a significant 
reduction in collagen cross-linking, associated with improper collagen fibril formation 
[49. Russell A.Norris, Brook Damon,2007]. Periostin is also shown to support BMP-
1 mediated proteolytic activation of lysyl oxidase on the extracellular matrix, which 
promotes collagen cross-linking and determines the properties of connective tissues 
that are constantly subjected to mechanical stress [55.Takumi Maruhashi, Isao 
Kii.(2010) ]. Periostin (POSTN) is discovered as a member of vitamin K-dependent 
γ-carboxylated protein family characterized by the presence of fasciclin domains. 
The most abundant Gla-containing protein secreted by bone marrow derived 
mesenchymal stromal cells. Periostin may be the bone-associated Gla-containg 
protein with similar function to Matrix Gla Protein (MGP) and Osteocalcin (OC), both 
of them are considered to be inhibitors of mineralization [28. Luo G, Ducy P,1997. 
29. N.R.Kaipatur, M. Murshed, 2008. 30. Hauschka, P.V., Lian, B.J. 1989. 31. 
Daniel L. Coutu, Jian Hui Wu, 2008]. The γ-carboxylation on the fasciclin domain 
of periostin may modulate cell-ECM interaction and provide hydroxyapatite binding 
properties [31. Daniel L. Coutu, Jian Hui Wu,2008] . One experiment demonstrated 
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that loss of Fam20C function in mice led to a remarkable loss of alveolar bone and 
cementum, inflammation of the periodontal ligament, severe periodontal disease, 
along with a significant reduction in the SIBLING proteins and periostin [44. Peihong 
Liu, Hua Zhang,2014]. 
In this study, FAM20C is the most abundant peptides found in the MS.  
FAM20C is a secreted Golgi casein kinase. It phosphorylates secretory pathway 
proteins within S-x-E motifs. The secreted proteins include a family of secretory 
calcium-binding phosphoproteins (SCPP) that have a high affinity for calcium, and 
regulate biomineralization. Phosphorylated S-x-E motifs bind calcium and regulate 
calcium phosphate precipitation as hydroxyapatite (HA). Raine syndrome, as the 
increased bone mass, could be explained by decreased phosphorylation of proteins 
and peptides that inhibit biomineralization. Mutations in FAM20C, incapable of 
limiting bone formation, leads to osteosclerotic bone dysplasia in humans with 
neonatal lethal outcome, known as Raine syndrome. It can be concluded that 
phosphorylation plays an important role in regulating biomineralization and inhibiting 
abnormal precipitation in humans [51. Vincent S. Tagliabracci, James L. Engel, 
2012. 34.  Fradin M, Stoetzel C, Muller J.(2010). 52. Sharon Grubner, Jung Hsin 
Lin.(2013).] One of the mutants is D478A. It was used in this study because 
previous studies of Golgi casein kinase showed FAM20C-D478A doesn’t have 
kniase activity. Also, using the FAM20C-WT and FAM20C-D478A proteins to find 
binding proteins of FAM20C, kinase-dependent and kinase-independent binding 
proteins might be able to differentiate. In the study, more amounts of FAM20C-
D478A were required to achieve the similar expression to FAM20C-WT. It’s 
probably because FAM20C-D478A lacks kinase activity and have more binding 
proteins. This may support that FAM20C protein have post-modifications, such as 
phosphorylation and glycosylation. 
Periostin (POSTN) is the only protein that is found in band 3 and band 6. 
HSPG2 is present in all bands except band 3. Besides periostin, HSPG2 and NID2, 
LAMB2, A2MG, PRP1, and GRN were noted in band 4, 5 and 6. There are more 
proteins binding to FAM20C-D478A than FAM20C-WT. It is assumed that FAM20C-
D478A lacks the kinase activity so that its substrates could not be phosphorylated 
and retained with FAM20C-D478A. For example, PRP1, a secreted phosphoprotein 
found in saliva, still binds to FAM20C-D478A. Ruling out the proteins in cytoplasm 
and proteins with less frequency in the analysis, periostin and HSPG2 are highly 
suspected as the binding proteins of FAM20C. Therefore, the following experiment 
was decided to check whether or not FAM20C binds to periostin and determine the 
possible interaction between these two proteins. Periostin can regulate collagen 
fibrillogenesis and determine the biomechanical properties of the connective tissues 
by regulating the crosslinking of collagen fibrils, which also play a vital role in the 
mechanism of mineralization. It is reasonable to speculate that FAM20C- periostin 
interaction is important for PDL integrity. FAM20C might phosphorylate periostin 
and upregulate periostin to control the unmineralized status in the connective 
tissues, such as periodontal ligament and periosteum. Future studies should be 
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warranted to determine the possible phosphorylation site(s) of periostin by FAM20C 
and the functional role of phosphorylation in periostin in PDL tissues. 
Binding of FAM20C to periostin (POSTN) 
 
Based on the binding experiment of FAM20C-V5 and periostin -HA in this 
study, the result shows that all forms of periostin, i.e. periostin -HA, periostin dCTR-
HA, periostin dEMI-HA, and periostin dEMI-CTR-HA were bound to FAM20C. 
Periostin may be phosphorylated by FAM20C and the phosphorylated sites may 
locate in the middle four fasciclin domains. It coincides with the amino acid 
sequences of mPeriostin isoform1 that has four sites that are S-x-E motifs and 
might be phosphorylated by FAM20C (Fig.16).  
 
Analyzing the amino acid sequence from previous study [Coutu et al, JBC, 
2008], periostin in human beings has 3 probable FAM20C phosphorylation sites 
(Fig.16A), while periostin isoform in mice has 4 probable phosphorylation sites 
(Fig.16B).  To compare the amino acid sequence from MS analysis to the sequence 
in human periostin, the sequence derived from MS analysis was underlined in the 
human periostin. The underlined peptides, the segments of periostin found in band 
3 and band 6, didn’t contain any of these phosphorylation sites (Fig.17). 
 
  It is known that some noncollagenous proteins play important roles in 
maintaining the unmineralized status in saliva and periodontal ligament by means of 
posttranslational modification, such as phosphorylation. For example, statherin and 
acidic proline-rich proteins in saliva interact with calcium and phosphate ion clusters 
with their negatively charged residues, like phosphoserine, to inhibit precipitation 
and crystal growth of hydroxyapatite [19. Raj PA, Johnsson M, 1992]. Several 
noncollagenous proteins [11. C. Qin, O Baba, 2004], such as bone sialoprotein, 
osteopontin and matrix” Gla” protein [28. Luo G, Ducy P,1997. 29. N.R.Kaipatur, M. 
Murshed, 2008], have been indicated to attract calcium and control mineralization 
process. A novel protein, follicular dendritic cell secreted protein (FDC-SP) has also 
been identified in human periodontal ligament [24. Monther Al-Alwan, Qiujiang Du, 
2007. 25. Sayaka Nakamura, Tatsuo Terashima, 2005. 26. Xiang L, Ma L, 2013]. 
The molecular properties, organization and function of FDC-SP are very similar to 
statherin. It has been proven that FDC-SP overexpression inhibits osteogenic 
differentiation of human periodontal ligament cells. Phosphorylation plays an 
important role in regulating biomineralization and inhibiting abnormal precipitation in 
humans based on the characteristics of Raine syndrome, which FAM20C is mutated 
and not phosphorylated. 
 
 The suspected of molecular weight of FAM20C is 66 Dka. After purification 
of FAM20C from conditioned media in the study, strong expression was noted at 
around 100 kDa and less strong expression at around 170 kDa. Bands at 170 kDa 
were observed in all the results. Covalent binding of FAM20C proteins or post-
modification may be the possible explanations. Post-modification, such as 
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glycosylation, of FAM20C was hypothesized and finding the binding proteins of 
FAM20C was the second goal of the experiment.  
In this study, it is concluded that periostin is one of the FAM20C binding 
proteins. Further studies are required to verify the binding is direct or indirect. 
Moreover, periostin may be phosphorylated by FAM20C and the phosphorylation 
may regulate the biomineralization of extracellular matrix where periostin is located. 
It will be an interesting future aim to test whether periostin is phosphorylated by 
FAM20C or not and to further investigate the role of phosphorylation for periostin. 
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>human FAM20C-WT 
MKMMLVRRFR VLILMVFLVA CALHIALDLL PRLERRGARP SGEPGCSCAQ 
PAAEVAAPGW AQVRGRPGEP PAASSAAGDA GWPNKHTLRI LQDFSSDPSS 100 
NLSSHSLEKL PPAAEPAERA LRGRDPGALR PHDPAHRPLL RDPGPRRSES 
PPGPGGDASL LARLFEHPLY RVAVPPLTEE DVLFNVNSDT RLSPKAAENP 200 
DWPHAGAEGA EFLSPGEAAV DSYPNWLKFH IGINRYELYS RHNPAIEALL 
HDLSSQRITS VAMKSGGTQL KLIMTFQNYG QALFKPMKQT REQETPPDFF 300 
YFSDYERHNA EIAAFHLDRI LDFRRVPPVA GRMVNMTKEI RDVTRDKKLW 
RTFFISPANN ICFYGECSYY CSTEHALCGK PDQIEGSLAA FLPDLSLAKR 400 
KTWRNPWRRS YHKRKKAEWE VDPDYCEEVK QTPPYDSSHR ILDVMDMTIF 
DFLMGNMDRH HYETFEKFGN ETFIIHLDNG RGFGKYSHDE LSILVPLQQC 500 
CRIRKSTYLR LQLLAKEEYK LSLLMAESLR GDQVAPVLYQ PHLEALDRRL 
RVVLKAVRDC VERNGLHSVV DDDLDTEHRA ASARLESRGP FEGKPIPNPL 
LGLDSTRTGH HHHHH 
>human FAM20C-D478A 
MKMMLVRRFR VLILMVFLVA CALHIALDLL PRLERRGARP SGEPGCSCAQ 
PAAEVAAPGW AQVRGRPGEP PAASSAAGDA GWPNKHTLRI LQDFSSDPSS 100 
NLSSHSLEKL PPAAEPAERA LRGRDPGALR PHDPAHRPLL RDPGPRRSES 
PPGPGGDASL LARLFEHPLY RVAVPPLTEE DVLFNVNSDT RLSPKAAENP 200 
DWPHAGAEGA EFLSPGEAAV DSYPNWLKFH IGINRYELYS RHNPAIEALL 
HDLSSQRITS VAMKSGGTQL KLIMTFQNYG QALFKPMKQT REQETPPDFF 300 
YFSDYERHNA EIAAFHLDRI LDFRRVPPVA GRMVNMTKEI RDVTRDKKLW 
RTFFISPANN ICFYGECSYY CSTEHALCGK PDQIEGSLAA FLPDLSLAKR 400 
KTWRNPWRRS YHKRKKAEWE VDPDYCEEVK QTPPYDSSHR ILDVMDMTIF 
DFLMGNMDRH HYETFEKFGN ETFIIHLANG RGFGKYSHDE LSILVPLQQC 500 
CRIRKSTYLR LQLLAKEEYK LSLLMAESLR GDQVAPVLYQ PHLEALDRRL 
RVVLKAVRDC VERNGLHSVV DDDLDTEHRA ASARLESRGP FEGKPIPNPL 
LGLDSTRTGH HHHHH 
 
FIGURE1. Protein sequence of FAM20C-WT and FAM20C-D478A with V5/His 
tag.	Note that Aspartic acid at position 478 of FAM20C-D478A was replaced by 
alanine, which is highlighted in red, and V5 tag with 6 X Histidine regions were 
shown in bold letters.	
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FIGURE2. Expression of FAM20C-WT or FAM20C-D478A protein. The 293 cells 
were transfected with pcDNA3.1-empty-V5/His, pcDNA3.1- human FAM20C WT-
V5/His and pcDNA3.1- human FAM20C D478A-V5/His. The cell lysate was 
collected and was immunoprecipitated with anti-V5 antibody. The expression of 
FAM20C-WT and –D478A was confirmed by Western blotting using anti-V5 AP 
antibody. 
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FIGURE3. Western blot analysis of stably transfected clones expressing 
FAM20C-WT and –D478A. A &B,10 single colony-derived clones transfected with 
either FAM20C-WT or FAM20C-D478A were isolated and transferred to 24-well 
plates. Western blotting with anti-V5 AP antibody for these clones was performed. C, 
Three clones with higher FAM20C expression were selected and the expression 
was confirmed. 
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FIGURE4. Purification of FAM20C proteins from conditioned media using Ni-
NTA system. Conditioned media from one of the selected FAM20C-WT and 
FAM20C-D478A clones were collected and Ni-NTA agarose was added to purify the 
FAM20C-WT-V5/His and –D478A-V5/His proteins. Proteins were then eluted into 
fractions with Native Elution Buffer. Forty µl of sample from each fraction was taken, 
applied to SDS-PAGE, and Western Blotting was performed with anti-V5 AP 
antibody. The immunoreactive bands are observed at around 100kDa and some 
additional bands at ~170 kDa. 
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FIGURE5. Western blot analysis with anti-FAM20C antibody. The positive 
fractions (Fig. 4) were combined, dialyzed against distilled water, samples were 
lyophilized and resuspended in distilled water. The protein concentration was 
measured. The expression of FAM20C-WT and –D478A was confirmed by Western 
blotting (WB) using anti-V5 AP antibody and anti-FAM20C antibody after purification. 
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FIGURE6.  Purification of FAM20C proteins from cell lysates using Ni-NTA 
system. The cell pellets of FAM20C-WT and FAM20C-D478A were collected after 
trypsin treatment and were resuspended in Native Binding Buffer with protease 
inhibitors. Cells were sheared by two cycles of frozen-thawed treatment and by 
passing through 16-gauge needle four times. After centrifuge, the supernatant was 
taken, Ni-NTA agarose was added to purify the FAM20C-WT-V5/His and –D478A-
V5/His proteins and was then under incubation. After incubation, the cell lysate was 
poured into the columns and washed with Native Wash Buffer. Then, proteins were 
eluted into fractions with Native Elution Buffer.  Forty µl of sample from each 
fraction was taken, applied to SDS-PAGE, and Western Blotting was done with anti-
V5 AP antibody. The immunoreactive bands are observed at around 100 kDa and 
some additional bands at ~170 kDa. 
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FIGURE7. Expression of purified FAM20C proteins from conditioned media 
and cell lysates. Purified FAM20C proteins from conditioned media and from 
lysates were taken and confirmed by Western blotting (WB) using anti-V5 antibody. 
Ten ng of purified FAM20C –WT proteins from conditioned media was needed to be 
detected in the Western blot but 0.4µg of purified FAM20C-WT proteins from the 
lysate was needed. Similarly, 75 ng of purified FAM20C-D478A proteins from 
conditioned media was needed to be detected obviously in the Western blot but 2.5 
µg of FAM20C-D478A proteins from the lysate was needed. It proved that FAM20C 
proteins can be purified from both purification methods. It also showed that 
FAM20C proteins were more easily purified from conditioned media than from cell 
lysates. 
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FIGURE8. Protein identification by Mass Spectrometry (MS) analysis. 2.5µg, 
5µg and 7.5µg of FAM20C-WT and 10µg and 15µg of FAM20C-D478A purified 
proteins from conditioned media were taken and loaded to the SDS-PAGE. The gel 
was stained by CBB and the bands stained were cut into segments. The segmented 
gels were subjected to Mass spectrometric analysis. Arrow 1-3 indicates the bands 
from FAM20C-WT proteins. Arrow 1 indicates a band detected slightly above 170 
kDa, arrow 2 slightly below 170 kDa and arrow 3 near 85 kDa. Arrow 4-6 indicates 
the bands from FAM20C-D478A  proteins. Arrow4 indicates a band detected slightly 
above 170 kDa, arrow 5 slightly below 170 kDa, and arrow 6 close to 85 kDa. 
Bovine serum albumin (BSA) proteins were used as a control group and no obvious 
band was noted. It was not shown in the picture, which is a missing part in this 
thesis. 
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FIGURE9. Protein identification derived from band 1. Analysis was performed by 
excluding the proteins located in cytoplasm first. HSPG2, TNC, FN1, IGHG1 and 
ITIH2 are all extracellular proteins and possible FAM20 binding proteins. Compared 
the band1 to the other bands, HSPG2 is the most frequently possible binding 
protein and may be a stronger binding substrate.  
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FIGURE10. Protein identification derived from band 2. HSPG2, TNC, IGHG1, 
FN1, NID2 are all extracellular proteins. The most frequently protein is HSPG2 and 
the second most is TNC.  
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FIGURE11. Protein identification derived from band 3. POSTN (periostin) is the 
extracellular protein that may be the binding protein of FAM20C. 
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FIGURE12. Protein identification derived from band 4. Compared with other 
bands, HSPG2, A2MG, TNC, FN1, PRP1, IGHG1, LAMB2, and NID2 are 
extracellular proteins and are more likely to be the binding proteins of FAM20C. 
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FIGURE13. Protein identification derived from band 5. HSPG2, A2MG, FN1, 
NID2, and TNC are extracellular proteins that may be the binding proteins of 
FAM20C. 
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FIGURE14. Protein identification derived from band 6. HSPG2, PRP1, POSTN 
(periostin), ITIH2, and GRN are extracellular proteins that may be the binding 
proteins of FAM20C. 
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FIGURE15. Binding of FAM20C to periostin (POSTN). HEK 293 cells were 
transiently transfected with periostin-WT-HA, periostin-dCTR-HA, periostin-dEMI-
HA, periostin-dEMI-CTR-HA and FAM20C-V5. The binding between periostin and 
FAM20C was investigated by  immunoprecipitation (IP) with anti-V5 antibody and 
Western blotting (WB) using anti-HA antibody. The result showed that periostin-HA, 
periostin-dCTR-HA, periostin-dEMI-HA, periostin-dEMI-dCTR-HA all bound to 
FAM20C.  
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A. 
 
MIPFLPMFSL LLLLIVNPIN ANNHYDKILA HSRIRGRDQG PNVCALQQIL 
GTKKKYFSTC KNWYKKSICG QKTTVLYECC PGYMRMEGMK GCPAVLPIDH 100 
VYGTLGIVGA TTTQRYSDAS KLREEIEGKG SFTYFAPSNE AWDNLDSDIR  
RGLESNVNVE LLNALHSHMI NKRMLTKDLK NGMIIPSMYN NLGLFINHYP 200 
NGVVTVNCAR IIHGNQIATN GVVHVIDRVL TQIGTSIQDF IEAEDDLSSF 
RAAAITSDIL EALGRDGHFT LFAPTNEAFE KLPRGVLERI MGDKVASEAL 300 
MKYHILNTLQ CSESIMGGAV FETLEGNTIE IGCDGDSITV NGIKMVNKKD 
IVTNNGVIHL IDQVLIPDSA KQVIELAGKQ QTTFTDLVAQ LGLASALRPD 400 
GEYTLLAPVN NAFSDDTLSM DQRLLKLILQ NHILKVKVGL NELYNGQILE 
TIGGKQLRVF VYRTAVCIEN SCMEKGSKQG RNGAIHIFRE IIKPAEKSLH 500 
EKLKQDKRFS TFLSLLEAAD LKELLTQPGD WTLFVPTNDA FKGMTSEEKE 
ILIRDKNALQ NIILYHLTPG VFIGKGFEPG VTNILKTTQG SKIFLKEVND 600 
TLLVNELKSK ESDIMTTNGV IHVVDKLLYP ADTPVGNDQL LEILNKLIKY 
IQIKFVRGST FKEIPVTVYT TKIITKVVEP KIKVIEGSLQ PIIKTEGPTL 700 
TKVKIEGEPE FRLIKEGETI TEVIHGEPII KKYTKIIDGV PVEITEKETR 
EERIITGPEI KYTRISTGGG ETEETLKKLL QEEVTKVTKF IEGGDGHLFE 800 
DEEIKRLLQG DTPVRKLQAN KKVQGSRRRL REGRSQ 
 
B. 
MVPLLPLYAL LLLFLCDINP ANANSYYDKV LAHSRIRGRD QGPNVCALQQ 
ILGTKKKYFS SCKNWYQGAI CGKKTTVLYE CCPGYMRMEG MKGCPAVMPI 100 
DHVYGTLGIV GATTTQHYSD VSKLREEIEG KGSYTYFAPS NEAWENLDSD 
IRRGLENNVN VELLNALHSH MVNKRMLTKD LKHGMVIPSM YNNLGLFINH 200 
YPNGVVTVNC ARVIHGNQIA TNGVVHVIDR VLTQIGTSIQ DFLEAEDDLS 
SFRAAAITSD LLESLGRDGH FTLFAPTNEA FEKLPRGVLE RIMGDKVASE 300 
ALMKYHILNT LQCSEAITGG AVFETMEGNT IEIGCEGDSI SINGIKMVNK 
KDIVTKNGVI HLIDEVLIPD SAKQVIELAG KQQTTFTDLV AQLGLASSLK 400 
PDGEYTLLAP VNNAFSDDTL SMDQRLLKLI LQNHILKVKV GLSDLYNGQI 
LETIGGKQLR VFVYRTAICI ENSCMVRGSK QGRNGAIHIF REIIQPAEKS 500 
LHDKLRQDKR FSIFLSLLEA ADLKDLLTQP GDWTLFAPTN DAFKGMTSEE 
RELLIGDKNA LQNIILYHLT PGVYIGKGFE PGVTNILKTT QGSKIYLKGV 600 
NETLLVNELK SKESDIMTTN GVIHVVDKLL YPADIPVGND QLLELLNKLI  
KYIQIKFVRG STFKEIPMTV YRPAMTKIQI EGDPDFRLIK EGETVTEVIH 700 
GEPVIKKYTK IIDGVPVEIT EKQTREERII TGPEIKYTRI STGGGETGET 
LQKFLQKEVS KVTKFIEGGD GHLFEDEEIK RLLQGDTPAK KIPANKRVQG 800 
PRRRSREGRS Q 
 
1-23: Signal peptide 
42-89: EMI 
111-232: Fasciclin 1 
247-369: Fasciclin 2 
384-496: Fasciclin 3 
509-633: Fasciclin 4 
634-811: CTR 
FIGURE16. Protein sequences of human periostin and mouse periostin 
Isoform1. A.,The human periostin has 3 probable S-X-E phosphorylation sites. B., 
The mouse periostin isoform 1 has 4 probable phosphorylation sites. [Coutu et al, 
JBC, 2008]. 
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A. 
 
MIPFLPMFSL LLLLIVNPIN ANNHYDKILA HSRIRGRDQG PNVCALQQIL 
GTKKKYFSTC KNWYKKSICG QKTTVLYECC PGYMRMEGMK GCPAVLPIDH 100 
VYGTLGIVGA TTTQRYSDAS KLREEIEGKG SFTYFAPSNE AWDNLDSDIR  
RGLESNVNVE LLNALHSHMI NKRMLTKDLK NGMIIPSMYN NLGLFINHYP 200 
NGVVTVNCAR IIHGNQIATN GVVHVIDRVL TQIGTSIQDF IEAEDDLSSF 
RAAAITSDIL EALGRDGHFT LFAPTNEAFE KLPRGVLERI MGDKVASEAL 300 
MKYHILNTLQ CSESIMGGAV FETLEGNTIE IGCDGDSITV NGIKMVNKKD 
IVTNNGVIHL IDQVLIPDSA KQVIELAGKQ QTTFTDLVAQ LGLASALRPD 400 
GEYTLLAPVN NAFSDDTLSM DQRLLKLILQ NHILKVKVGL NELYNGQILE 
TIGGKQLRVF VYRTAVCIEN SCMEKGSKQG RNGAIHIFRE IIKPAEKSLH 500 
EKLKQDKRFS TFLSLLEAAD LKELLTQPGD WTLFVPTNDA FKGMTSEEKE 
ILIRDKNALQ NIILYHLTPG VFIGKGFEPG VTNILKTTQG SKIFLKEVND 600 
TLLVNELKSK ESDIMTTNGV IHVVDKLLYP ADTPVGNDQL LEILNKLIKY 
IQIKFVRGST FKEIPVTVYT TKIITKVVEP KIKVIEGSLQ PIIKTEGPTL 700 
TKVKIEGEPE FRLIKEGETI TEVIHGEPII KKYTKIIDGV PVEITEKETR 
EERIITGPEI KYTRISTGGG ETEETLKKLL QEEVTKVTKF IEGGDGHLFE 800 
DEEIKRLLQG DTPVRKLQAN KKVQGSRRRL REGRSQ 
 
B. 
MIPFLPMFSL LLLLIVNPIN ANNHYDKILA HSRIRGRDQG PNVCALQQIL 
GTKKKYFSTC KNWYKKSICG QKTTVLYECC PGYMRMEGMK GCPAVLPIDH 100 
VYGTLGIVGA TTTQRYSDAS KLREEIEGKG SFTYFAPSNE AWDNLDSDIR  
RGLESNVNVE LLNALHSHMI NKRMLTKDLK NGMIIPSMYN NLGLFINHYP 200 
NGVVTVNCAR IIHGNQIATN GVVHVIDRVL TQIGTSIQDF IEAEDDLSSF 
RAAAITSDIL EALGRDGHFT LFAPTNEAFE KLPRGVLERI MGDKVASEAL 300 
MKYHILNTLQ CSESIMGGAV FETLEGNTIE IGCDGDSITV NGIKMVNKKD 
IVTNNGVIHL IDQVLIPDSA KQVIELAGKQ QTTFTDLVAQ LGLASALRPD 400 
GEYTLLAPVN NAFSDDTLSM DQRLLKLILQ NHILKVKVGL NELYNGQILE 
TIGGKQLRVF VYRTAVCIEN SCMEKGSKQG RNGAIHIFRE IIKPAEKSLH 500 
EKLKQDKRFS TFLSLLEAAD LKELLTQPGD WTLFVPTNDA FKGMTSEEKE  
ILIRDKNALQ NIILYHLTPG VFIGKGFEPG VTNILKTTQG SKIFLKEVND 600 
TLLVNELKSK ESDIMTTNGV IHVVDKLLYP ADTPVGNDQL LEILNKLIKY 
IQIKFVRGST FKEIPVTVYT TKIITKVVEP KIKVIEGSLQ PIIKTEGPTL 700 
TKVKIEGEPE FRLIKEGETI TEVIHGEPII KKYTKIIDGV PVEITEKETR 
EERIITGPEI KYTRISTGGG ETEETLKKLL QEEVTKVTKF IEGGDGHLFE 800 
DEEIKRLLQG DTPVRKLQAN KKVQGSRRRL REGRSQ 
FIGURE17. Peptides of human periostin found in band 3 and band 6. A., The 
underlined peptides are the segments of periostin found in band 3. B., The 
underlined peptides are segments of periostin found in band 6. No segments 
included the possible phosphorylation sites, highlighted letter S. Both segments 
showed that there is no possible phosphorylation site in the fragmented periostin 
binding to FAM20C-WT or FAM20C-D478A in the purified samples from conditioned 
media. 
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